Home Biosimilar Antibodies Immunology & Inflammation IL Receptor Anti-IL-13Ra2 / CD213a2 For research use only.
Not for use in humans.

Anti-IL-13Ra2 / CD213a2

Anti-IL-13Ra2 / CD213a2 is a humanized monoclonal antibody targeting IL-13Ra2. It exhibits potentcy against malignant gliomas (MG), head and neck tumors, ovarian cancer and kidney cancer. MW :150 KD.

Anti-IL-13Ra2 / CD213a2

Purity & Quality Control

≥99

Choose Selective IL Receptor Inhibitors

Biological Activity

Description Anti-IL-13Ra2 / CD213a2 is a humanized monoclonal antibody targeting IL-13Ra2. It exhibits potentcy against malignant gliomas (MG), head and neck tumors, ovarian cancer and kidney cancer. MW :150 KD.

Product Details

Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Anti-IL-13Ra2 / CD213a2 | Anti-IL-13Ra2 / CD213a2 supplier | purchase Anti-IL-13Ra2 / CD213a2 | Anti-IL-13Ra2 / CD213a2 cost | Anti-IL-13Ra2 / CD213a2 manufacturer | order Anti-IL-13Ra2 / CD213a2 | Anti-IL-13Ra2 / CD213a2 distributor